| EXAMINATION | - J T Lewis ET AL, "Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist", Endocrinology, (20001001), vol. 141, no. 10, doi:10.1210/en.141.10.3710, ISSN 0013-7227, pages 3710 - 3716, XP055174431 | |
| OPPOSITION | - A Nelson, "Antibody fragments, Hope and hype", mAbs, (20100101), pages 71 - 83, mAbs, URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828581/pdf/mabs0201_0077.pdf, (20150619), XP055197059 | - |
| OPPOSITION | - Anonymous, "2.2. Quality aspects", European medicines agency - EMA/CHMP/524604/2014, (20140925), pages 15 - 15, XP093287999 | - |
| OPPOSITION | - Anonymous, "gastric inhibitory polypeptide receptor isoform 1 precursor [Homo sapiens]", Protein , (20161008), Database accession no. NP_000155, XP093290084 | - |
| OPPOSITION | - Anonymous, "gastric inhibitory polypeptide receptor isoform 2 precursor [Homo sapiens]", Protein , (20161008), Database accession no. NP_001295347, XP093290087 | - |
| OPPOSITION | - Anonymous, "International Nonproprietary Names for Pharmaceutical Substances (INN) RECOMMENDED International Nonproprietary Names (Rec. INN): L", WHO DRUG INFORMATION, GENEVA, CH, CH , (20030609), vol. 17, no. 2, ISSN 1010-9609, pages 115 - 142, XP093290097 | - |
| OPPOSITION | - Anonymous, "International Nonproprietary Names for Pharmaceutical Substances (INN) ", WHO Drug Information, Recommended INN: List 65, (20110101), vol. 25, no. 1, pages 49 - 98, XP093266611 | - |
| OPPOSITION | - Anonymous, "Medical genetics", Wikipedia, pages 1 - 14, Wikipedia, URL: https://en.wikipedia.org/w/index.php?title=Medical_genetics&oldid=698209514, XP093290098 | - |
| OPPOSITION | - Chantal Ginestoux, "IMGT Scientific chart", URL: http://www.imgt.org/IMGTScientificChart/Numbering/Hu_IGHGnber.html, (20180216), XP055452106 | - |
| OPPOSITION | - D27 - Inherited metabolic disorders | - |
| OPPOSITION | - D2 - Priority Application as filed (US62,447,332) | - |
| OPPOSITION | - D59 - Product information for anti-GLP-1R mouse antibody STJ72859, St John’s Laboratory, Ltd. | - |
| OPPOSITION | - Oldham Brian, Irwin Linnie, Koester Anja, Klimmey Ulrike, Chadwell Fred, Clutinger Cathleen, Tian Yu, Showalter Hollis, Cummins Robert, Ellis Bernice, Zhang Lianshan, Schwargarus Nancy, Kunkel Aaron, Brenner Martin, Chen Yanyun, Etgen Gary, Rogers Amanda, Hardy Thomas, Millican Wolgang, Glaesner Jenny, Chien John, Mayer Hans-Juergen, Mest Philip, Barrington Andrew, Vick Richard, Zink, "Optimization of a long-acting PEGylated GLP-1 agonist LY2428757", ACS Fall 2012; August 21 - 25 | Philadelphia, PA, ACS, (20120821), pages 1 - 1, XP093290092 | - |
| OPPOSITION | - Ontology Gene, "P48546 · GIPR_HUMAN", UNIPROT, (19960201), Database accession no. GIPR_HUMAN, URL: UNIPOROTKB, XP093288049 | - |
| OPPOSITION | - Strohl William R., "Therapeutic Monoclonal Antibodies: Past, Present, and Future", Strohl William R., Zhiqiang An, Therapeutic Monoclonal Antibodies : From Bench to Clinic, Wiley, (20090928), pages 1 - 50, doi:10.1002/9780470485408.ch1, ISBN 978-0-470-48540-8, XP093288042 | |
| OPPOSITION | - Ying Wang; Jintang Du; Huafei Zou; Yan Liu; Yuhan Zhang; Jose Gonzalez; Elizabeth Chao; Lucy Lu; Pengyu Yang; Holly Parker; Van Nguyen‐Tran; Weijun Shen; Danling Wang; Peter G. Schultz; Feng Wang, "Multifunctional Antibody Agonists Targeting Glucagon‐like Peptide‐1, Glucagon, and Glucose‐Dependent Insulinotropic Polypeptide Receptors", Angewandte Chemie, Verlag Chemie, Hoboken, USA, Hoboken, USA, (20160906), vol. 55, no. 40, doi:10.1002/anie.201606321, ISSN 1433-7851, pages 12475 - 12478, XP072094201 | |
| OPPOSITION | - N. Irwin ; P. R. Flatt, "Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications", Diabetologia, Springer, Berlin, DE, Berlin, DE , (20090617), vol. 52, no. 9, doi:10.1007/s00125-009-1422-8, ISSN 1432-0428, pages 1724 - 1731, XP019735348 | |
| OPPOSITION | - Schumacher Dominik; Hackenberger Christian P.; Leonhardt Heinrich; Helma Jonas, "Current Status: Site-Specific Antibody Drug Conjugates", JOURNAL OF CLINICAL IMMUNOLOGY, New York , (20160322), vol. 36, no. 1, doi:10.1007/s10875-016-0265-6, ISSN 0271-9142, pages 100 - 107, XP035837954 | |
| OPPOSITION | - Xiaoying Chen, Jennica L. Zaro, Wei-Chiang Shen, "Fusion protein linkers: Property, design and functionality", NIH Public Access Author Manuscript, (20131001), doi:10.1016/j.addr.2012.09.039, pages 1 - 32, XP055341428 | |
| OPPOSITION | - Sparre-Ulrich A.H.; Gabe M.N.; Gasbjerg L.S.; Christiansen C.B.; Svendsen B.; Hartmann B; Holst J.J.; Rosenkilde M.M., "GIP(3-30)NH2is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release", Biochemical Pharmacology, US , (20170222), vol. 131, doi:10.1016/j.bcp.2017.02.012, ISSN 0006-2952, pages 78 - 88, XP029949834 | |
| OPPOSITION | - Irwin, N. ; Flatt, P.R., "Therapeutic potential for GIP receptor agonists and antagonists", Best Practice & Research Clinical Endocrinology & Metabolism, BAILLIERE TINDALL, LONDON, GB, GB , (20090801), vol. 23, no. 4, doi:10.1016/j.beem.2009.03.001, ISSN 1521-690X, pages 499 - 512, XP026581640 | |
| OPPOSITION | - Alicja M. Sochaj, Karolina W. Świderska, Jacek Otlewski, "Current methods for the synthesis of homogeneous antibody-drug conjugates", BIOTECHNOLOGY ADVANCES, GB , (20151101), vol. 33, no. 6, doi:10.1016/j.biotechadv.2015.05.001, ISSN 0734-9750, pages 775 - 784, XP055268076 | |
| OPPOSITION | - Finan Brian; Clemmensen Christoffer; Zhu Zhimeng; Stemmer Kerstin; Gauthier Karine; Müller Luisa; De Angelis Meri; Moreth Kristin; Neff Frauke; Perez-Tilve Diego; Fischer Katrin; Lutter Dominik; Sánchez-Garrido Miguel A.; Liu Peng; Tuckermann Jan; Malehmir Mohsen; Healy Marc E.; Weber Achim; Heikenwalder Mathias; Jastroch Martin; Kleinert Maximilian; Jall Sigrid; Brandt Sara; Flamant Frédéric; Schramm Karl-Werner; Biebermann Heike; Döring Yvonne; Weber Christian; Habegger Kirk M.; Keuper Michaela; Gelfanov Vasily; Liu Fa; Köhrle Josef; Rozman Jan; Fuchs Helmut; Gailus-Durner Valerie; Hrabě de Angelis Martin; Hofmann Susanna M.; Yang Bin; Tschöp Matthias H.; DiMarchi Richard; Müller Timo D., "Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (20161006), vol. 167, no. 3, doi:10.1016/j.cell.2016.09.014, ISSN 0092-8674, page 843, XP029773978 | |
| OPPOSITION | - Pavel Strop, Shu-Hui Liu, Magdalena Dorywalska, Kathy Delaria, Russell g. Dushin, Thomas-Toan Tran, Wei-Hsien Ho, Santiago Farias, Meritxell galindo Casas, Yasmina Abdiche, Dahui Zhou, Ramalakshmi Chandrasekaran, Caroline Samain, Carole Loo, Andrea Rossi, Mathias Rickert, Stellanie Krimm, Teresa Wong, Sherman michael Chin, Jessica Yu, Jeanette Dilley, Javier Chaparro-Riggers, Gary f. Filzen, Christopher j. O’donnell, Fang Wang, Jeremy s. Myers, Jaume Pons, David l. Shelton, Arvind Rajpal, "Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates", Chemistry & Biology, (20130201), vol. 20, no. 2, doi:10.1016/j.chembiol.2013.01.010, ISSN 10745521, pages 161 - 167, XP055094948 | |
| OPPOSITION | - Shepelyakovskaya A.O.; Laman A.G.; Lomonosova A.V.; Fursova K.K.; Savinov G.V.; Vertiev Yu.V.; Brovko F.A.; Grishin E.V., "Effect of the format of antibodies on their specificity", Molecular Immunology, GB , (20111001), vol. 49, no. 3, doi:10.1016/j.molimm.2011.09.017, ISSN 0161-5890, pages 433 - 440, XP028598574 | |
| OPPOSITION | - Vogel Heike; Wolf Stefanie; Rabasa Cristina; Rodriguez-Pacheco Francisca; Babaei Carina S.; Stöber Franziska; Goldschmidt Jürgen; DiMarchi Richard D.; Finan Brian; Tschöp Matthias H.; Dickson Suzanne L.; Schürmann Annette; Skibicka Karolina P., "GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight", Neuropharmacology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20160802), vol. 110, doi:10.1016/j.neuropharm.2016.07.039, ISSN 0028-3908, pages 396 - 406, XP029733853 | |
| OPPOSITION | - Daisuke Yabe; Yutaka Seino;, "Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and cell preservation", Progress in Biophysics and Molecular Biology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , vol. 107, no. 2, doi:10.1016/j.pbiomolbio.2011.07.010, ISSN 0079-6107, pages 248 - 256, XP028323556 | |
| OPPOSITION | - Pan Yingying; Shi Siwei; Lao Xun; Zhang Jinlong; Tan Shiming; Wu Zirong; Huang Jing, "A novel GLP-1 analog, a dimer of GLP-1 via covalent linkage by a lysine, prolongs the action of GLP-1 in the treatment of type 2 diabetes", Peptides, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20161210), vol. 88, doi:10.1016/j.peptides.2016.11.009, ISSN 0196-9781, pages 46 - 54, XP029893886 | |
| OPPOSITION | - Chiu Mark L; Gilliland Gary L, "Engineering antibody therapeutics", Current Opinion in Structural Biology, Elsevier Ltd., GB, GB , (20160812), vol. 38, doi:10.1016/j.sbi.2016.07.012, ISSN 0959-440X, pages 163 - 173, XP029707735 | |
| OPPOSITION | - Karunaratne Sachini P., Moussa Ehab M., Mills Brittney J., Weis David D., "Understanding the Effects of Site-Specific Light Chain Conjugation on Antibody Structure Using Hydrogen Exchange-Mass Spectrometry (HX-MS)", Journal of pharmaceutical sciences, (20240801), vol. 113, no. 8, doi:10.1016/j.xphs.2024.05.008, ISSN 0022-3549, pages 2065 - 2071, XP093288019 | |
| OPPOSITION | - Gordon Mallory R., Canakci Mine, Li Longyu, Zhuang Jiaming, Osborne Barbara, Thayumanavan S., "Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists", Bioconjugate Chemistry - Author Manuscript, US , (20151118), vol. 26, no. 11, doi:10.1021/acs.bioconjchem.5b00399, ISSN 1043-1802, pages 1 - 44, XP093288024 | |
| OPPOSITION | - Biswas Kaustav, Nixey Thomas E., Murray Justin K., Falsey James R., Yin Li, Liu Hantao, Gingras Jacinthe, Hall Brian E., Herberich Brad, Holder Jerry Ryan, Li Hongyan, Ligutti Joseph, Lin Min-Hwa Jasmine, Liu Dong, Soriano Brian D., Soto Marcus, Tran Linh, Tegley Christopher M., Zou Anrou, Gunasekaran Kannan, Moyer Bryan D., Doherty Liz, Miranda Les P., "Engineering Antibody Reactivity for Efficient Derivatization to Generate Na V 1.7 Inhibitory GpTx-1 Peptide-Antibody Conjugates", ACS CHEMICAL BIOLOGY, American Chemical Society, (20170915), vol. 12, no. 9, doi:10.1021/acschembio.7b00542, ISSN 1554-8929, pages 2427 - 2435, XP093290062 | |
| OPPOSITION | - Bikash Manandhar, Jung-Mo Ahn, "Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications", Journal of Medicinal Chemistry, American Chemical Society, US, US , (20150212), vol. 58, no. 3, doi:10.1021/jm500810s, ISSN 0022-2623, pages 1020 - 1037, XP055402142 | |
| OPPOSITION | - Migyeong Jo, Sang Taek Jung, "Engineering therapeutic antibodies targeting G-protein-coupled receptors", Experimental & Molecular Medicine, (20160201), vol. 48, no. 2, doi:10.1038/emm.2015.105, pages 1 - 9, XP055546956 | |
| OPPOSITION | - DAY JONATHAN W, ET AL, "A new glucagon and GLP-1 co-agonist eliminates obesity in rodents.", Nature Chemical Biology, Nature Publishing Group US, New York, New York, (20091001), vol. 5, no. 10, doi:10.1038/nchembio.209, ISSN 1552-4450, pages 749 - 757, XP002558889 | |
| OPPOSITION | - Catherine J. Hutchings, Markus Koglin, William C. Olson, Fiona H. Marshall, "Opportunities for therapeutic antibodies directed at G-protein-coupled receptors", Nature Reviews Drug Discovery, GB , (20170101), vol. 16, no. 11, doi:10.1038/nrd.2017.91, ISSN 1474-1776, pages 787 - 810, XP055473894 | |
| OPPOSITION | - HU QI-YING, "Towards the next generation of biomedicines by site-selective conjugation", CHEMICAL SOCIETY REVIEWS, (20160321), vol. 45, no. 6, doi:10.1039/C4CS00388H, pages 1691 - 1719, XP002772944 | |
| OPPOSITION | - J. Y. Axup, K. M. Bajjuri, M. Ritland, B. M. Hutchins, C. H. Kim, S. A. Kazane, R. Halder, J. S. Forsyth, A. F. Santidrian, K. Stafin, Y. Lu, H. Tran, A. J. Seller, S. L. Biroc, A. Szydlik, J. K. Pinkstaff, F. Tian, S. C. Sinha, B. Felding-Habermann, V. V. Smider, P. G. Schultz, "Synthesis of site-specific antibody-drug conjugates using unnatural amino acids", Proceedings of the National Academy of Sciences, (20121002), vol. 109, no. 40, doi:10.1073/pnas.1211023109, ISSN 00278424, pages 16101 - 16106, XP055076257 | |
| OPPOSITION | - RUDIKOFF S,, "Single amino acid substitution altering antigen-binding specificity.", Proceedings of the National Academy of Sciences (PNAS), (19820301), vol. 79, no. 6, doi:10.1073/pnas.79.6.1979, ISSN 0027-8424, pages 1979 - 1983, XP002683593 | |
| OPPOSITION | - Peter Ravn, Chaithanya Madhurantakam, Susan Kunze, Evelyn Matthews, Claire Priest, Siobhan O'brien, Andie Collinson, Monika Papworth, Maria Fritsch-Fredin, Lutz Jermutus, Lambertus Benthem, Markus Gruetter, Ronald H. Jackson, "Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor", Journal of Biological Chemistry, US , (20130705), vol. 288, no. 27, doi:10.1074/jbc.M112.426288, ISSN 0021-9258, pages 19760 - 19772, XP055355497 | |
| OPPOSITION | - Könitzer Jennifer D., Pramanick Shreya, Pan Qi, Augustin Robert, Bandholtz Sebastian, Harriman William, Izquierdo Shelley, "Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptor", mAbs, US , vol. 9, no. 3, doi:10.1080/19420862.2016.1276683, ISSN 1942-0862, (20170403), pages 536 - 549, mAbs, URL: https://pubmed.ncbi.nlm.nih.gov/28055305/, XP093288010 | |
| OPPOSITION | - A H Sparre‐Ulrich; L S Hansen; B Svendsen; M Christensen; F K Knop; B Hartmann; J J Holst; M M Rosenkilde, "Species‐specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors", British journal of pharmacology, UK , (20151120), vol. 173, no. 1, doi:10.1111/bph.13323, ISSN 0007-1188, pages 27 - 38, XP071094456 | |
| OPPOSITION | - Sten Madsbad, "Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists", Diabetes, Obesity and Metabolism, Blackwell Science, GB, GB , (20151229), vol. 18, no. 4, doi:10.1111/dom.12596, ISSN 1462-8902, pages 317 - 332, XP072204564 | |
| OPPOSITION | - Jonathan D Roth; Mary R Erickson; Steve Chen; David G Parkes, "GLP‐1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities", British journal of pharmacology, Wiley-Blackwell, UK, UK , (20120410), vol. 166, no. 1, doi:10.1111/j.1476-5381.2011.01537.x, ISSN 0007-1188, pages 121 - 136, XP071171089 | |
| OPPOSITION | - Li Yazhou, Glotfelty Elliot J., Karlsson Tobias, Fortuno Lowella V., Harvey Brandon K., Greig Nigel H., "Author manuscript: The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration", Journal of Neurochemistry, Wiley-Blackwell Publishing Ltd., GB, GB , (20211201), vol. 159, no. 5, doi:10.1111/jnc.15521, ISSN 0022-3042, pages 1 - 35, XP093290057 | |
| OPPOSITION | - Rod Dimaline, Andrea Varro, "Novel roles of gastrin", The Journal of Physiology, Wiley-Blackwell Publishing Ltd., GB, GB , (20140715), vol. 592, no. 14, doi:10.1113/jphysiol.2014.272435, ISSN 0022-3751, pages 2951 - 2958, XP055292030 | |
| OPPOSITION | - Ma Yanbin, Ding Yao, Song Xianqiang, Ma Xiaochuan, Li Xun, Zhang Ning, Song Yunpeng, Sun Yaping, Shen Yuqing, Zhong Wenge, Hu Liaoyuan A., Ma Yingli, Zhang Mei-Yun, "Structure-guided discovery of a single-domain antibody agonist against human apelin receptor", Science Advances, (20200117), vol. 6, no. 3, doi:10.1126/sciadv.aax7379, pages 1 - 9, XP093101268 | |
| OPPOSITION | - Boylan Michael O., Glazebrook Patricia A., Tatalovic Milos, Wolfe M. Michael, "Gastric inhibitory polypeptide immunoneutralization attenuates development of obesity in mice", American Journal of Physiology-Endocrinology and Metabolism, US , (20151215), vol. 309, no. 12, doi:10.1152/ajpendo.00345.2015, ISSN 0193-1849, pages E1008 - E1018, XP093288001 | |
| OPPOSITION | - McClean P L, "GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high -fat diet", AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM, US , (20070101), vol. 293, no. 6, doi:10.1152/ajpendo.00460.2007, ISSN 0193-1849, pages E 1746 - E 1755, XP008099009 | |
| OPPOSITION | - Suleiman Al-Sabah, "Molecular Pharmacology of the Incretin Receptors", MEDICAL PRINCIPLES AND PRACTICE, CH , (20160101), vol. 25, no. 1, doi:10.1159/000433437, ISSN 1011-7571, pages 15 - 21, XP055475051 | |
| OPPOSITION | - J T Lewis, Dayanandan B, Habener J F, Kieffer T J, "Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist", Endocrinology, (20001001), vol. 141, no. 10, doi:10.1210/en.141.10.3710, ISSN 00137227, pages 3710 - 3716, XP055174431 | |
| OPPOSITION | - Anonymous, "15 - Antibody-drug conjugates", Anonymous, William R. Strohl, L. M. Strohl, and Lila M. Strohl, Therapeutic Antibody Engineering, GB , Woodhead Publishing Limited , (20120101), pages 345 - 375, doi:10.1533/978190S818096.345, ISBN 978-1-907568-37-4, XP093288021 | |
| OPPOSITION | - Bo Ahrén, "GLP-1 receptor agonists in the treatment of Type 2 diabetes", Diabetes Management, Future Medicine Ltd., UK, UK , (20130901), vol. 3, no. 5, doi:10.2217/dmt.13.41, ISSN 1758-1907, pages 401 - 413, XP055445603 | |
| OPPOSITION | - C. Clemmensen, "GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet", Diabetes, (20140401), vol. 63, no. 4, doi:10.2337/db13-1609, ISSN 0012-1797, pages 1422 - 1427, XP055395929 | |
| OPPOSITION | - Fukuda Makoto, "The Role of GIP Receptor in the CNS for the Pathogenesis of Obesity", Diabetes, American Diabetes Association :, (20210901), vol. 70, no. 9, doi:10.2337/dbi21-0001, ISSN 0012-1797, pages 1929 - 1937, XP093290082 | |
| OPPOSITION | - Bak Mijeong, Junyong Park, Kiyoon Min, Jinhwan Cho, Jihyoun Seong, Young S Hahn, Giyoong Tae, Inchan Kwon , "Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide", Pharmaceutics, (20200416), doi:10.3390/pharmaceutics12040364, XP055871349 | |
| OPPOSITION | - Park Junyong, Bak Mijeong, Min Kiyoon, Kim Hyun-Woo, Cho Jeong-Haeng, Tae Giyoong, Kwon Inchan, "Effect of C-terminus Conjugation via Different Conjugation Chemistries on In Vivo Activity of Albumin-Conjugated Recombinant GLP-1", Pharmaceutics, MDPI AG, Switzerland, Switzerland, vol. 13, no. 2, doi:10.3390/pharmaceutics13020263, ISSN 1999-4923, page 263, XP093244774 | |
| OPPOSITION | - Naver Signe V, Jimenez-Solem Espen, Christensen Mikkel, Andersen Jon T, Knop Filip K, "Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist", Clinical Investigation, Future Science, UK, UK , (20140801), vol. 4, no. 8, doi:10.4155/cli.14.65, ISSN 2041-6792, pages 729 - 743, XP093290054 | |
| OPPOSITION | - Christopher R Behrens, Bin Liu, "Methods for site-specific drug conjugation to antibodies", mAbs, US , (20140120), vol. 6, no. 1, doi:10.4161/mabs.26632, ISSN 1942-0870, pages 46 - 53, XP055293357 | |
| OPPOSITION | - Prasad-Reddy Lalita, Isaacs Diana, "A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond", DRUGS IN CONTEXT (INTERNATIONAL EDITION), C S F MEDICAL COMMUNICATIONS LTD.,, UK, UK , (20150709), vol. 4, doi:10.7573/dic.212283, ISSN 1745-1981, pages 212283 - 19, XP093290039 | |
